Skip to main content

Table 2 GCRG213p expression in intestinal metaplasia (IM), dysplasia and gastric adenocarcinoma

From: Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia

Lesions

N

Cases of overall scorea

PRb (%)

P value

0–2

3

4–5

6

IM

47

24

7

6

10

48.94

 

Dysplasia

7

3

1

2

1

57.14

P = 0.956c

Gastric adenocarcinoma

47

21

11

10

5

55.32

 

Well-to-moderately-differentiated

14

3

3

4

4

78.57

P = 0.036d

Poorly-differentiated

33

18

6

4

5

45.45

 
  1. aOverall score calculated as (intensity score) plus (percent cells positive score) as described in methods
  2. bPR: Positive rate of GCRG213p expression
  3. cAmong gastric IM, dysplasia and adenocarcinoma
  4. dBetween well-to-moderately-differentiated and poorly-differentiated adenocarcinoma